US4486414A
(en)
|
1983-03-21 |
1984-12-04 |
Arizona Board Of Reagents |
Dolastatins A and B cell growth inhibitory substances
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
FR2613935B1
(fr)
|
1987-04-15 |
1989-12-01 |
Roussel Uclaf |
Association renfermant a titre de principes actifs, un analgesique central et la forskoline
|
US4816444A
(en)
|
1987-07-10 |
1989-03-28 |
Arizona Board Of Regents, Arizona State University |
Cell growth inhibitory substance
|
US5076973A
(en)
|
1988-10-24 |
1991-12-31 |
Arizona Board Of Regents |
Synthesis of dolastatin 3
|
US4978744A
(en)
|
1989-01-27 |
1990-12-18 |
Arizona Board Of Regents |
Synthesis of dolastatin 10
|
US4986988A
(en)
|
1989-05-18 |
1991-01-22 |
Arizona Board Of Regents |
Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13
|
US5138036A
(en)
|
1989-11-13 |
1992-08-11 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Isolation and structural elucidation of the cytostatic cyclodepsipeptide dolastatin 14
|
JPH0688488B2
(ja)
|
1990-10-23 |
1994-11-09 |
豊治 藤本 |
ペルチェ電子素子型の可搬式エアコン及び換気性衣服
|
EP0598129B1
(en)
|
1991-08-09 |
2000-03-22 |
Teikoku Hormone Mfg. Co., Ltd. |
Novel tetrapeptide derivative
|
CA2081406C
(en)
|
1991-12-23 |
1997-09-16 |
Chinmoy Bhusan Bose |
Method and apparatus for connected and degraded text recognition
|
CZ292612B6
(cs)
|
1992-05-20 |
2003-11-12 |
Abbott Gmbh & Co. Kg |
Peptid s protirakovinnou aktivitou, jeho použití a farmaceutický prostředek s obsahem takového peptidu
|
US5831002A
(en)
|
1992-05-20 |
1998-11-03 |
Basf Aktiengesellschaft |
Antitumor peptides
|
US5635483A
(en)
|
1992-12-03 |
1997-06-03 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Tumor inhibiting tetrapeptide bearing modified phenethyl amides
|
US6034065A
(en)
|
1992-12-03 |
2000-03-07 |
Arizona Board Of Regents |
Elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10
|
JPH06172397A
(ja)
|
1992-12-11 |
1994-06-21 |
Nippon Kayaku Co Ltd |
新規物質ドラスタチンc及びその用途
|
AU679479B2
(en)
|
1992-12-16 |
1997-07-03 |
Basf Aktiengesellschaft |
Dolostatin analog
|
US5410024A
(en)
|
1993-01-21 |
1995-04-25 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide amides
|
US5780588A
(en)
|
1993-01-26 |
1998-07-14 |
Arizona Board Of Regents |
Elucidation and synthesis of selected pentapeptides
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
ATE282630T1
(de)
|
1993-10-01 |
2004-12-15 |
Teikoku Hormone Mfg Co Ltd |
Dolastatin-derivate
|
WO1996002576A1
(fr)
|
1994-07-13 |
1996-02-01 |
Chugai Seiyaku Kabushiki Kaisha |
Anticorps humain reconstitue contre l'interleukine-8 humaine
|
US5530097A
(en)
|
1994-08-01 |
1996-06-25 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory peptide amides
|
US5521284A
(en)
|
1994-08-01 |
1996-05-28 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide amides and esters
|
US5504191A
(en)
|
1994-08-01 |
1996-04-02 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide methyl esters
|
US5840699A
(en)
|
1995-04-21 |
1998-11-24 |
Teikoku Hormone Mfg. Co. Ltd. |
Peptide derivatives
|
DE19527575A1
(de)
|
1995-07-28 |
1997-01-30 |
Basf Ag |
Verfahren zur Herstellung von peptidischer Wirkstoffe
|
JPH0977791A
(ja)
|
1995-09-08 |
1997-03-25 |
Nippon Kayaku Co Ltd |
ペプチド誘導体及びその用途
|
US5816444A
(en)
|
1995-10-23 |
1998-10-06 |
Calico Light Weapon Systems |
Rotor and ratchet assembly
|
US5807984A
(en)
|
1995-11-09 |
1998-09-15 |
Basf Aktienegesellschaft |
Oligopeptides, the preparation and use thereof
|
US5939527A
(en)
|
1996-07-30 |
1999-08-17 |
Basf Aktiengesellschaft |
Tetrapeptides as antitumor agents
|
US5741892A
(en)
|
1996-07-30 |
1998-04-21 |
Basf Aktiengesellschaft |
Pentapeptides as antitumor agents
|
US6239104B1
(en)
|
1997-02-25 |
2001-05-29 |
Arizona Board Of Regents |
Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18
|
US5965537A
(en)
|
1997-03-10 |
1999-10-12 |
Basf Aktiengesellschaft |
Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
|
US6103698A
(en)
|
1997-03-13 |
2000-08-15 |
Basf Aktiengesellschaft |
Dolastatin-15 derivatives in combination with taxanes
|
US6143721A
(en)
|
1997-07-18 |
2000-11-07 |
Basf Aktiengesellschaft |
Dolastatin 15 derivatives
|
EP1049481B1
(en)
|
1997-09-24 |
2005-04-20 |
Arizona Board Of Regents |
Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
|
US6677436B1
(en)
|
1998-04-03 |
2004-01-13 |
Chugai Seiyaku Kabushiki Kaisha |
Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody
|
WO1999054342A1
(en)
|
1998-04-20 |
1999-10-28 |
Pablo Umana |
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
|
US5985837A
(en)
|
1998-07-08 |
1999-11-16 |
Basf Aktiengesellschaft |
Dolastatin 15 derivatives
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
ES2568899T3
(es)
|
1999-04-09 |
2016-05-05 |
Kyowa Hakko Kirin Co., Ltd. |
Procedimiento para controlar la actividad de una molécula inmunofuncional
|
US6323315B1
(en)
|
1999-09-10 |
2001-11-27 |
Basf Aktiengesellschaft |
Dolastatin peptides
|
FR2807767B1
(fr)
|
2000-04-12 |
2005-01-14 |
Lab Francais Du Fractionnement |
Anticorps monoclonaux anti-d
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
US7256257B2
(en)
|
2001-04-30 |
2007-08-14 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
US6737409B2
(en)
|
2001-07-19 |
2004-05-18 |
Hoffmann-La Roche Inc. |
Dolastatin 10 derivatives
|
PT1545613E
(pt)
|
2002-07-31 |
2011-09-27 |
Seattle Genetics Inc |
Conjugados de auristatina e sua utilização para tratamento do cancro, de uma doença autoimune ou de uma doença infecciosa
|
US7355008B2
(en)
|
2003-01-09 |
2008-04-08 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
US8388955B2
(en)
|
2003-03-03 |
2013-03-05 |
Xencor, Inc. |
Fc variants
|
SG10201701737XA
(en)
|
2003-11-06 |
2017-04-27 |
Seattle Genetics Inc |
Monomethylvaline compounds capable of conjugation to ligands
|
DE10359795A1
(de)
|
2003-12-19 |
2005-07-21 |
Bayer Technology Services Gmbh |
Strangverdampfervorrichtung
|
EP1817336B1
(en)
|
2004-11-12 |
2019-01-09 |
Seattle Genetics, Inc. |
Auristatins having an aminobenzoic acid unit at the n terminus
|
EP1817341A2
(en)
|
2004-11-29 |
2007-08-15 |
Seattle Genetics, Inc. |
Engineered antibodies and immunoconjugates
|
BRPI0519023A2
(pt)
|
2004-12-13 |
2008-12-23 |
Hoffmann La Roche |
composiÇço farmacÊutica contendo pelo menos um derivado de dolastatina 10
|
JP5171621B2
(ja)
|
2005-07-07 |
2013-03-27 |
シアトル ジェネティックス, インコーポレイテッド |
フェニルアラニン側鎖修飾をc末端に有するモノメチルバリン化合物
|
PT2322221E
(pt)
|
2008-08-05 |
2014-09-19 |
Toray Industries |
Composição farmacêutica para tratamento e prevenção de cancro
|
US20120213705A1
(en)
|
2009-06-22 |
2012-08-23 |
Medimmune, Llc |
ENGINEERED Fc REGIONS FOR SITE-SPECIFIC CONJUGATION
|
CA2773240C
(en)
|
2009-09-22 |
2015-11-10 |
Volker Sandig |
Process for producing molecules containing specialized glycan structures
|
JP5845899B2
(ja)
|
2010-02-04 |
2016-01-20 |
東レ株式会社 |
癌の治療及び/又は予防用医薬組成物
|
PT2532743E
(pt)
|
2010-02-04 |
2015-08-04 |
Toray Industries |
Composição farmacêutica para o tratamento e/ou a prevenção de cancro
|
MX2012008991A
(es)
|
2010-02-04 |
2012-09-07 |
Toray Industries |
Medicamento para tratar y/o prevenir el cancer.
|
ES2583777T3
(es)
|
2010-02-04 |
2016-09-22 |
Toray Industries, Inc. |
Composición farmacéutica que comprende anticuerpos anti CAPRIN-1 para el tratamiento y/o la prevención del cáncer
|
DK2532366T3
(da)
|
2010-02-04 |
2017-01-02 |
Toray Industries |
Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer
|
EP2532365B1
(en)
|
2010-02-04 |
2016-05-04 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
BR112012024489A2
(pt)
|
2010-03-29 |
2016-05-31 |
Zymeworks Inc |
anticorpos com função efetora suprimida ou aumentada
|
EP2579887B1
(de)
|
2010-06-10 |
2014-11-12 |
Seattle Genetics, Inc. |
Neue auristatin-derivate und ihre verwendung
|
US9029406B2
(en)
|
2011-03-16 |
2015-05-12 |
Seattle Genetics, Inc |
N-carboxyalkylauristatins and use thereof
|
EP2699268A2
(de)
|
2011-04-21 |
2014-02-26 |
Seattle Genetics, Inc. |
Neue binder-wirkstoff konjugate (adcs) und ihre verwendung
|
WO2012148943A1
(en)
|
2011-04-25 |
2012-11-01 |
Arizona Board Of Regents, For And On Behalf Of, Arizona State University |
Crystal structures of dolastatin 16, dolamethylleuine and dolaphenvaline, and methods for preparing dolamethylleuine and dolaphenvaline
|
CA2837167A1
(en)
|
2011-05-27 |
2012-12-06 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
|
EP3470413A3
(en)
|
2011-05-27 |
2019-08-07 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
|
JP6003650B2
(ja)
|
2011-08-04 |
2016-10-05 |
東レ株式会社 |
膵臓癌の治療及び/又は予防用医薬組成物
|
EP2740798B1
(en)
|
2011-08-04 |
2016-12-07 |
Toray Industries, Inc. |
Cancer treatment and/or prevention drug composition
|
PT3351630T
(pt)
|
2011-08-04 |
2019-12-30 |
Toray Industries |
Composição farmacêutica compreendendo anticorpos anti caprin-1 para tratar e/ou prevenir o cancro
|
JP6065591B2
(ja)
|
2011-08-04 |
2017-01-25 |
東レ株式会社 |
癌の治療及び/又は予防用医薬組成物
|
KR101968498B1
(ko)
|
2011-08-04 |
2019-04-12 |
도레이 카부시키가이샤 |
암의 치료 및/또는 예방용 의약 조성물
|
KR101980557B1
(ko)
|
2011-08-04 |
2019-05-21 |
도레이 카부시키가이샤 |
암의 치료 및/또는 예방용 의약 조성물
|
EP2764351B1
(en)
|
2011-09-29 |
2018-11-07 |
Seattle Genetics, Inc. |
Intact mass determination of protein conjugated agent compounds
|
RU2633505C2
(ru)
|
2012-02-21 |
2017-10-12 |
Торэй Индастриз, Инк. |
Фармацевтическая композиция для лечения и/или профилактики рака
|
AU2013223137B2
(en)
|
2012-02-21 |
2017-10-19 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
MX360208B
(es)
|
2012-02-21 |
2018-10-24 |
Toray Industries |
Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
|
CA2864869C
(en)
|
2012-02-21 |
2021-10-19 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
PL2832365T3
(pl)
|
2012-03-30 |
2018-04-30 |
Toray Industries, Inc. |
Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi wątroby
|
JP6107655B2
(ja)
|
2012-03-30 |
2017-04-05 |
東レ株式会社 |
胆嚢癌の治療及び/又は予防用医薬組成物
|
CA3131619A1
(en)
|
2012-05-15 |
2013-11-21 |
Seagen Inc. |
Self-stabilizing linker conjugates
|
CN112587671A
(zh)
|
2012-07-18 |
2021-04-02 |
博笛生物科技有限公司 |
癌症的靶向免疫治疗
|
JP6089108B2
(ja)
|
2012-09-20 |
2017-03-01 |
セルトリオン, インク. |
ドラスタチン10誘導体、その製造方法およびそれを含む抗癌剤組成物
|
FR3005051A1
(fr)
|
2013-04-25 |
2014-10-31 |
Pf Medicament |
Derives de la dolastatine 10 et d'auristatines
|
JP6447130B2
(ja)
|
2013-08-09 |
2019-01-09 |
東レ株式会社 |
癌の治療及び/又は予防用医薬組成物
|
MX2021008464A
(es)
|
2013-10-15 |
2023-03-03 |
Seattle Genetics Inc |
Farmaco-enlazadores modificados con polietilenglicol para la farmacocinetica mejorada de conjugados de ligando-farmaco.
|
IL290330B2
(en)
|
2013-12-19 |
2023-09-01 |
Seagen Inc |
Methylene carbamate binders for use with drug-targeting conjugates
|
EP3100731A4
(en)
*
|
2014-01-29 |
2017-12-20 |
Shanghai Hengrui Pharmaceutical Co., Ltd. |
Ligand-cytotoxicity drug conjugate, preparation method therefor, and uses thereof
|
KR102647074B1
(ko)
|
2014-02-17 |
2024-03-14 |
씨젠 인크. |
친수성 항체-약물 컨쥬게이트
|
CN106279352B
(zh)
|
2015-05-29 |
2020-05-22 |
上海新理念生物医药科技有限公司 |
海兔毒素10的衍生物及其应用
|
KR102626498B1
(ko)
|
2016-03-25 |
2024-01-19 |
씨젠 인크. |
페길화된 약물-링커 및 그의 중간체의 제조를 위한 공정
|
CN108779146B
(zh)
|
2016-03-29 |
2022-03-18 |
东丽株式会社 |
肽衍生物及其用途
|
MX2019001302A
(es)
|
2016-08-09 |
2019-06-12 |
Seattle Genetics Inc |
Conjugados de farmaco con enlazadores autoestabilizantes que tienen propiedades fisioquimicas mejoradas.
|
BR112019008335A2
(pt)
*
|
2016-10-28 |
2020-01-28 |
Toray Industries |
conjugado de um anticorpo, composição farmacêutica e método para o tratamento e/ou a prevenção de um câncer
|
JP7244987B2
(ja)
|
2016-12-14 |
2023-03-23 |
シージェン インコーポレイテッド |
多剤抗体薬物コンジュゲート
|
CN110352074A
(zh)
|
2017-02-28 |
2019-10-18 |
西雅图遗传学公司 |
用于偶联的半胱氨酸突变抗体
|
AU2019225845A1
(en)
|
2018-02-20 |
2020-09-24 |
Seagen Inc. |
Hydrophobic Auristatin F compounds and conjugates thereof
|
CN109796522B
(zh)
|
2019-02-18 |
2021-09-21 |
清远中大创新药物研究中心 |
海兔毒素10环肽衍生物及其制备方法和应用
|
EP4051691A4
(en)
|
2019-10-28 |
2023-11-08 |
Ariel Scientific Innovations Ltd. |
DOLASTATIN 10 ANALOG
|
CA3170633A1
(en)
|
2020-03-09 |
2021-09-16 |
David Goeddel |
Efficient preparation of dolastatin and auristatin analogs through a common intermediate
|